Gustavo A. Fonseca, MD | Authors

REID HOSPITAL

1100 REID PKWY

Articles

Renal-Cell Carcinoma

April 01, 2005

Renal-cell carcinoma (RCC) is curable only in patients presenting with resectable, early-stage disease. Advanced local or metastatic disease carries an approximate 15% 5-year survival rate. However, the natural history of metastatic RCC is heterogeneous, and aggressive palliative treatment is recommended, especially for patients with a solitary metastatic site and good performance status.